Overview
Genetic head and neck malformation (Orphanet code 183583) is a broad classification category within Orphanet that encompasses a heterogeneous group of rare congenital malformations affecting the structures of the head and neck that have a confirmed or suspected genetic origin. This grouping includes a wide spectrum of developmental anomalies involving the craniofacial skeleton, ears, nose, oral cavity, pharynx, larynx, neck soft tissues, and associated structures. These malformations arise during embryonic development due to disruptions in the complex genetic programs that guide the formation of head and neck anatomy, often involving neural crest cell migration and differentiation, branchial arch development, or midline fusion processes. Because this is a classification group rather than a single discrete disease entity, the clinical presentation varies enormously depending on the specific condition involved. Affected individuals may present with craniofacial asymmetry, cleft lip or palate, ear malformations (microtia, anotia), mandibular or maxillary hypoplasia, nasal anomalies, branchial cleft cysts or fistulae, laryngeal or tracheal malformations, thyroid dysgenesis, or other structural abnormalities of the head and neck region. Many of these conditions are apparent at birth or during early childhood. Some occur as isolated findings, while others are part of broader syndromic conditions affecting multiple organ systems. Treatment approaches depend on the specific malformation and its severity. Management is typically multidisciplinary, involving clinical geneticists, craniofacial surgeons, otolaryngologists, orthodontists, speech therapists, and audiologists. Surgical correction is often the mainstay of treatment for structural anomalies, with timing and approach tailored to the individual condition. Genetic counseling is important for affected families to understand recurrence risks and inheritance patterns, which vary by specific diagnosis within this broad category.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
2 eventsEnsem Therapeutics — PHASE1, PHASE2
Eli Lilly and Company — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Genetic head and neck malformation.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Genetic head and neck malformation at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Genetic head and neck malformation.
Community
No community posts yet. Be the first to share your experience with Genetic head and neck malformation.
Start the conversation →Latest news about Genetic head and neck malformation
Disease timeline:
New recruiting trial: First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A new clinical trial is recruiting patients for Genetic head and neck malformation
New recruiting trial: Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
A new clinical trial is recruiting patients for Genetic head and neck malformation
New recruiting trial: A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
A new clinical trial is recruiting patients for Genetic head and neck malformation
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Genetic head and neck malformation
What is Genetic head and neck malformation?
Genetic head and neck malformation (Orphanet code 183583) is a broad classification category within Orphanet that encompasses a heterogeneous group of rare congenital malformations affecting the structures of the head and neck that have a confirmed or suspected genetic origin. This grouping includes a wide spectrum of developmental anomalies involving the craniofacial skeleton, ears, nose, oral cavity, pharynx, larynx, neck soft tissues, and associated structures. These malformations arise during embryonic development due to disruptions in the complex genetic programs that guide the formation
At what age does Genetic head and neck malformation typically begin?
Typical onset of Genetic head and neck malformation is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Genetic head and neck malformation?
21 specialists and care centers treating Genetic head and neck malformation are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.